Group 1 - The company, Lifen Holdings (01125.HK), will hold a board meeting on March 24, 2026, to consider and approve the unaudited interim results for the six months ending January 31, 2026, as well as the declaration of an interim dividend if applicable [1]

产品方面，搭载自研马赫100芯片的全新一代理想L9将于二季度正式上市，有效算力达英伟达Thor-U三 倍。理想i6月产能3月将攀升至2万辆，增程+纯电双轮驱动格局正式成型。 理想汽车公布2025年第四季度及全年财务业绩。全年营收1123亿元，净利润11亿元，成为国内唯一连续 三年营收破千亿、连续三年实现盈利的新势力车企。四季度营收288亿元，环比增长5.2%，Q4交付10.9 万辆，环比增长17.1%。截至年末现金储备1012亿元，位居新势力第一，季度自由现金流转正。 研发方面，全年研发投入113亿元创历史新高，AI相关投入占比50%，涵盖自研马赫100芯片、基座大模 型、星环OS操作系统等核心技术，软硬件一体化具身智能技术底座全面成型。 ...

Group 1 - China Biologic Products (01177.HK) announced that its subsidiary, Chengda Tianqing, has completed the interim analysis of the Phase III clinical study for TQB3454, an IDH1 inhibitor for advanced cholangiocarcinoma with IDH1 mutations, achieving the predefined efficacy thresholds for progression-free survival (PFS) and overall survival (OS) [1] - The study, TQB3454-III-01, is a randomized, double-blind, placebo-controlled, multi-center Phase III trial aimed at evaluating the efficacy and safety of TQB3454 in patients with advanced cholangiocarcinoma who have failed previous treatments [1] - The independent data monitoring committee (IDMC) determined that TQB3454 significantly reduces the risk of disease progression or death compared to the control group, significantly extending both PFS and OS [1] Group 2 - Cholangiocarcinoma (BTC) accounts for approximately 3% of all digestive system tumors, with over 200,000 new cases globally in 2021, and its incidence is on the rise [2] - BTC primarily consists of adenocarcinoma, characterized by high malignancy and poor prognosis, with a five-year survival rate of less than 5% [2] - IDH1 inhibitors are crucial for the precision treatment of cholangiocarcinoma, and currently, there are no approved drugs targeting this pathway in China, indicating a significant unmet clinical need [2]

Core Viewpoint - Great Wall Motors (02333.HK) announced that its board meeting will be held on March 27, 2026, to review and approve the audited annual performance for the year ending December 31, 2025, and to consider the distribution of dividends, if any [1] Group 1 - The board meeting will take place in Baoding, Hebei Province, China [1] - The financial results will be prepared in accordance with the Chinese Accounting Standards [1] - The meeting will also address the potential distribution of dividends [1]

Core Viewpoint - Great Wall Motors (02333.HK) announced that its board meeting will be held on March 27, 2026, in Baoding, Hebei Province, China, to review and approve the audited annual performance for the year ending December 31, 2025, and to consider the distribution of dividends, if any [1]. Group 1 - The board meeting is scheduled for March 27, 2026 [1] - The meeting will take place in Baoding, Hebei Province, China [1] - The agenda includes reviewing the audited annual performance for the year ending December 31, 2025 [1]

Core Viewpoint - MTR Corporation (00066.HK) reported a decline in annual performance for the year ending December 31, 2025, with total revenue decreasing by 7.6% to HKD 55.465 billion and net profit attributable to shareholders falling by 6.9% to HKD 14.677 billion [1] Financial Performance - Total revenue for the year was HKD 55.465 billion, a decrease of 7.6% year-on-year [1] - Net profit attributable to shareholders was HKD 14.677 billion, down 6.9% compared to the previous year [1] - Basic earnings per share were HKD 2.36 [1] - The proposed final ordinary dividend is HKD 0.89 per share, with total ordinary dividends for the year remaining at HKD 1.31 per share, unchanged from 2024 [1] Business Segments - The decline in net profit was influenced by increased depreciation in Hong Kong operations, a one-time impairment adjustment related to certain deferred rental reductions, and a decrease in contributions from mainland China operations [1] - The recurring profit attributable to shareholders from regular business operations was HKD 5.653 billion [1] - Property development profits increased to HKD 11.084 billion, benefiting from earlier launched property development projects during the period [1] - Under the "Railway plus Property" development model, most of the property development profits will be used for the construction and maintenance of future and existing railway projects in Hong Kong [1] - The basic business profit attributable to shareholders was HKD 16.737 billion [1]

Group 1 - The company NetDragon (00777.HK) announced a meeting scheduled for March 26, 2026, to discuss various matters [1] - The agenda includes reviewing and approving the audited consolidated final results for the year ending December 31, 2025, and publishing these results on the Hong Kong Stock Exchange and the company's website [1] - The company will consider the proposal for the payment of a final dividend, if any, and may discuss the suspension of share transfer registration if necessary [1] - Additional matters will also be addressed during the meeting [1]

格隆汇3月12日丨陆氏集团(越南)(00366.HK)公告，公司订于2026年3月26日(星期四)下午三时正举行董 事会会议，以(其中包括)批准公司及其附属公司截至2025年12月31日止年度业绩公布，以及考虑派发末 期股息(如有)。 ...

Group 1 - The company, Daphne International (00210.HK), will hold a board meeting on March 24, 2026, to approve the annual results for the year ending December 31, 2025, and to consider the proposal for a final dividend, if any [1]

Core Viewpoint - The company, Sinopharm (01801.HK), has announced that it will hold a board meeting on March 26, 2026, to consider and approve its annual performance for the year ending December 31, 2025, and to discuss the potential distribution of a final dividend, if any [1] Group 1 - The board meeting is scheduled for March 26, 2026 [1] - The meeting will focus on the annual performance for the year ending December 31, 2025 [1] - The company will also consider the proposal for a final dividend distribution [1]